EA-230
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for EA-230, covering 2016-06-23 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery. [Phase 3]